Livento Group, Inc. Discloses Issuance of Convertible Note in Recent 8-K Filing

Livento Group, Inc. revealed in a recent 8-K filing with the Securities and Exchange Commission that on August 1, 2022, the company had issued a convertible note amounting to $70,000. This note was issued to Durotar, Ltd., with funding from Durotar on the same day. The disclosure of this note was inadvertently omitted from previous SEC filings by the company. Consequently, Livento Group is now reporting the Note in good faith to facilitate a bona fide purchaser of the Note in its efforts to convert the Note and liquidate derived conversion shares.

According to the filing, Livento Group can be contacted at 17 Stete Street, Suite 4000, NY, 10004, with a telephone number of 980-432-8241. The company’s common stock, trading under the symbol NUGN on the OTC Pink exchange, has a par value of $0.0001 per share. Livento Group, Inc. operates in Nevada and holds the identification number 49-3999052.

David Stybr, President of Livento Group Inc., formerly known as NuGene International, Inc., signed the filing on behalf of the company on February 18, 2025.

This concludes the information presented in the recent 8-K filing by Livento Group, Inc. Investors and interested parties are encouraged to refer to the latest SEC filings for further details regarding the company’s financial activities and disclosures.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Livento Group’s 8K filing here.

About Livento Group

Livento Group, Inc engages in the film and television production business. It is also involved in the artificial intelligence and machine learning technology business; development and licensing of Elisee, a software product that can capture data and create predictive behavior based on client inputs that assist the client in establishing its investment portfolio; and real estate finance and development activities.